CBIA Company Profile and Key Details

The stock is currently trading near its 52-week high $0.00 and $0.00. With a market capitalization of about $455.07 thousand, Canopus Biopharma, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~9.07). Key stats such as the average daily volume over the past year has been around 5.54 million shares, in line with its 52-week average. Headquartered in Las Vegas, NV, Canopus Biopharma, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Patrick T. Prendergast, the company employs approximately 72 people and listed since December 31, 1999. Blue Heaven Coffee, Inc provides retail and digital advertising solutions.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Our AI price prediction model suggests that Canopus BioPharma Incorporated stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Canopus BioPharma Incorporated trading at a premium to the broader market with a P/E of -0.01.

Canopus BioPharma Incorporated trades at a P/E ratio of -0.01, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -0.83 indicating negative book value, which may reflect financial stress. The P/FCF stands at -73.64, also below market averages.